| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Ciena price target raised to $270 from $230 at Stifel on AI demand | ||
| Do | Uber adds regional grocery and alcohol retailers to delivery apps | ||
| Do | AlphaTON Capital signs 2.2 MW data center agreement with atNorth | ||
| Do | Kartoon Studios and AETH team up to launch live-action venture | ||
| Do | Rhythm Pharmaceuticals stock holds Buy rating at TD Cowen on PWS trial data | ||
| Do | Raymond James raises Electrovaya stock price target to $9.50 from $6.00 | ||
| Do | ALLETE acquisition by CPP Investments and GIP set to close Dec 15 | ||
| Do | Gedatolisib shows promising results in breast cancer trial | ||
| Do | Ciena stock price target raised to $250 from $120 at Raymond James | ||
| Do | DA Davidson lowers Lovesac stock price target to $18 on delayed product launch | ||
| Do | T1 Energy stock maintains Buy rating at Needham with $6.00 price target | ||
| Do | Smolyansky urges Lifeway shareholders to vote for board changes | ||
| Do | L3Harris demonstrates cross-agency communication capabilities | ||
| Do | Warby Parker stock price target raised to $32 from $25 at BTIG | ||
| Do | Enveric Biosciences secures $3.1 million through warrant exercise | ||
| Do | Mondelez International declares $0.50 quarterly dividend | ||
| Do | Morgan Stanley raises Rhythm Pharmaceuticals stock price target to $150 | ||
| Do | Jefferies lowers Parsons stock price target to $75 on slower growth | ||
| Do | HUB Cyber Security expands services with major European bank | ||
| Do | Rezolute stock price target cut to $5 from $17 at BTIG after trial failure | ||
| Do | Raymond James reiterates Strong Buy on Aardvark Therapeutics stock with $47 target | ||
| Do | Workato and Confluent partner to connect AI agents with enterprise systems | ||
| Do | Amazon Luna cloud gaming now available on Xfinity devices | ||
| Do | Hongkong Land to launch Singapore's largest private real estate fund | ||
| Do | GSK's Blujepa approved as oral treatment for gonorrhoea in US |